PSP Research »

Ptc Therapeutics I shares owned by PSP Research

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $535k 7.0k 75.96

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Ptc Therapeutics I

BlackRock
Vanguard Group
Rtw Investments
State Street Corporation
Wellington Management Company
Geode Capital Management
D. E. Shaw & Co
FMR
Leucadia National Corporation
Tang Capital Management
Franklin Resources
Citadel Advisors
Driehaus Capital Management
Point72 Asset Management
Goldman Sachs Group

View all funds holding Ptc Therapeutics I